Future Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
- Satisfied Charges ₹ 1.00 M
- Revenue Growth 32.67%
- Profit Growth 29.98%
- Ebitda 27.16%
- Net Worth 23.80%
- Total Assets -17.60%
About Future Pharma
Future Pharma Private Limited (FPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 February 2009 and has a history of 15 years and 11 months. Its registered office is in Kanpur Nagar, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Gupta, Lokesh Gupta, and Krishan Gupta serve as directors at the Company.
Company Details
-
Location
Kanpur Nagar, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85120UP2009PTC036892
-
Company No.
036892
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Feb 2009
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Future Pharma Private Limited offer?
Future Pharma Private Limited offers a wide range of products and services, including Vitamins & Supplements, Multivitamins, Health Conditions, Pain Relief.
Who are the key members and board of directors at Future Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Gupta
|
Director | 27-Feb-2009 | Current |
|
Lokesh Gupta
|
Director | 27-Feb-2009 | Current |
|
Krishan Gupta
|
Director | 27-Feb-2009 | Current |
Financial Performance of Future Pharma.
Future Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.67% increase. The company also saw a substantial improvement in profitability, with a 29.98% increase in profit. The company's net worth Soared by an impressive increase of 23.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Future Pharma?
In 2023, Future Pharma had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹20.00 M
₹1.00 M
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Sep 2024 | Others | ₹2.00 Cr | Open |
| 30 Oct 2019 | Others | ₹1.00 M | Satisfied |
How Many Employees Work at Future Pharma?
Future Pharma has a workforce of 273 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Future Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Future Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.